[1]庞海燕.雄激素及其受体在慢性肾脏病相关的血管钙化中的研究进展[J].国际内分泌代谢杂志,2022,42(05):387-390,400.[doi:10.3760/cma.j.cn121383-20220225-02064]
 Pang Haiyan..Research advances of androgen and androgen receptor in vascular calcification of chronic kidney disease[J].International Journal of Endocrinology and Metabolism,2022,42(05):387-390,400.[doi:10.3760/cma.j.cn121383-20220225-02064]
点击复制

雄激素及其受体在慢性肾脏病相关的血管钙化中的研究进展()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
42
期数:
2022年05期
页码:
387-390,400
栏目:
综述
出版日期:
2022-09-20

文章信息/Info

Title:
Research advances of androgen and androgen receptor in vascular calcification of chronic kidney disease
作者:
庞海燕
天津医科大学第二医院肾脏病血液净化科 300211
Author(s):
Pang Haiyan.
Department of Kidney Disease Blood Purification, Tianjin Medical University Second Hospital, Tianjin 300211, China
关键词:
雄激素 雄激素受体 血管钙化 慢性肾脏病
Keywords:
Androgen Androgen receptor Vascular calcification Chronic kidney disease
DOI:
10.3760/cma.j.cn121383-20220225-02064
摘要:
血管钙化是慢性肾脏病(CKD)的常见并发症,是CKD患者心血管事件增加的危险因素之一。CKD血管钙化的发病机制目前尚未完全明确,可能涉及多种病理生理过程如炎症反应、细胞凋亡、氧化应激、低氧反应等。CKD血管钙化中男性发病率显著高于女性,提示雄激素可能在CKD血管钙化的发展过程中发挥重要作用。本文对雄激素及雄激素受体与CKD血管钙化的相关性研究进行综述。
Abstract:
Vascular calcification is a common complication of chronic kidney disease(CKD), and is one of the risk factors for increased cardiovascular events in CKD.The pathogenesis of CKD vascular calcification is not fully clarified, and various pathophysiological processes such as inflammatory response, apoptosis, oxidative stress and hypoxic response may be the underlying reasons. The incidence of CKD vascular calcification is significantly higher in men than in women, showing that androgen may play an important role in the development of CKD vascular calcification. In this paper, the relevant studies of androgen and its receptor in CKD vascular calcification were reviewed in order to provide new ideas for deeply understanding the regulatory mechanism of CKD vascular calcification and seeking new targets for the treatment of CKD vascular calcification.

参考文献/References:

[1] Li W,Feng W,Su X,et al.SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease[J].J Clin Invest,2022,132(1):e150051.DOI:10.1172/JCI150051.
[2] Liu ZH,China Dialysis Calcification Study(CDCS)Group.Vascular calcification burden of Chinese patients with chronic kidney disease:methodology of a cohort study[J].BMC Nephrol,2015,16:129.DOI:10.1186/s12882-015-0132-3.
[3] Paloian NJ,Giachelli CM.A current understanding of vascular calcification in CKD[J].Am J Physiol Renal Physiol,2014,307(8):F891-900.DOI:10.1152/ajprenal.00163.2014.
[4] Hénaut L,Candellier A,Boudot C,et al.New insights into the roles of monocytes/macrophages in cardiovascular calcification associated with Chronic Kidney Disease[J].Toxins(Basel),2019,11(9):529.DOI:10.3390/toxins11090529.
[5] Viegas C,Araújo N,Marreiros C,et al.The interplay between mineral metabolism,vascular calcification and inflammation in Chronic Kidney Disease(CKD):challenging old concepts with new facts[J].Aging(Albany NY),2019,11(12):4274-4299.DOI:10.18632/aging.102046.
[6] Li Y,Sun Z,Zhang L,et al.Role of Macrophages in the Progression and Regression of Vascular Calcifification[J].Front Pharmacol,2020,11:661.DOI:10.3389/fphar.2020.00661.
[7] Agharazii M,St-Louis R,Gautier-Bastien A,et al.Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification[J].Am J Hypertens,2015,28(6):746-755.DOI:10.1093/ajh/hpu225.
[8] Wu PY,Lee SY,Chang KV,et al.Gender-Related Differences in Chronic Kidney Disease-Associated vascular calcification risk and potential risk mediators:a scoping review[J].healthcare(Basel),2021,9(8):979.DOI:10.3390/healthcare9080979.
[9] Pang H,Xiao L,Lu Z,et al.Targeting androgen receptor in macrophages inhibits phosphate-induced vascular smooth muscle cell calcification by decreasing IL-6 expression[J].Vascul Pharmacol,2020,130:106681.DOI:10.1016/j.vph.2020.106681.
[10] Kurozumi A,Nakano K,Yamagata K,et al.IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2[J].Bone,2019,124:53-61.DOI:10.1016/j.bone.2019.04.006.
[11] Jin D,Lin L,Xie Y,et al.NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease[J].FASEB J,2022,36(1):e22098.DOI:10.1096/fj.202100625RR.
[12] Chang JF,Liu SH,Lu KC.Uremic vascular calcification is correlated with oxidative elastic lamina injury,contractile smooth muscle cell loss,osteogenesis,and apoptosis:the human pathobiological evidence[J].Front Med,2020,7:78.DOI:10.3389/fmed.2020.00078.
[13] 庞海燕,卢志,肖龙飞,等.巨噬细胞雄激素受体通过调控白细胞介素1β基因表达影响高磷诱发的血管平滑肌细胞钙化[J].中华肾脏病杂志,2022,38(5):420-427.DOI:10.3760/cma.j.cn441217-20210408-00060.
[14] Huang M,Zheng L,Xu H,et al.Oxidative stress contributes to vascular calcification in patients with chronic kidney disease[J].J Mol Cell Cardiol,2020,138:256-268.DOI:10.1016/j.yjmcc.2019.12.006.
[15] Liu Y,Guo Y,Bao S,et al.Bone marrow mesenchymal stem cell-derived exosomal microRNA-381-3p alleviates vascular calcification in chronic kidney disease by targeting NFAT5[J].Cell Death Dis,2022,28; 13(3):278.DOI:10.1038/s41419-022-04703-1.
[16] Abbasian N.Vascular calcification mechanisms:updates and renewed insight into signaling pathways involved in high phosphate-mediated vascular smooth muscle cell calcification.Biomedicines[J].2021,9(7):804.DOI:10.3390/biomedicines9070804.
[17] Ciceri P,Falleni M,Tosi D,et al.Therapeutic effect of iron citrate in blocking calcium deposition in high Pi-Calcified VSMC:role of autophagy and apoptosis[J].Int J Mol Sci,2019,20(23):5925.DOI:10.3390/ijms20235925.
[18] Li M,Ye J,Zhao G,et al.Gas6 attenuates lipopolysaccharide-induced TNF-α expression and apoptosis in H9C2 cells through NF-κB and MAPK inhibition via the Axl/PI3K/Akt pathway[J].Int J Mol Med,2019,44(3):982-994.DOI:10.3892/ijmm.2019.4275.
[19] Duan S,Chen X,Liu Y,et al.Endoplasmic reticulum stress mediates parathyroid hormone-induced apoptosis in vascular smooth muscle cells[J].Ren Fail,2022,44(1):126-136.DOI:10.1080/0886022X.2022.2027248.
[20] Woodward HJ,Zhu D,Hadoke PWF,et al.Regulatory role of sex hormones in cardiovascular calcification[J].Int J Mol Sci,2021,22(9):4620.DOI:10.3390/ijms22094620.
[21] Son BK,Akishita M,Iijima K,et al.Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification[J].J Biol Chem,2010,285(10):7537-7544.DOI:10.1074/jbc.M109.055087.
[22] Nanao-Hamai M,Son BK,Komuro A,et al.Ginsenoside Rb1 inhibits vascular calcification as a selective androgen receptor modulator[J].Eur J Pharmacol,2019,859:172546.DOI:10.1016/j.ejphar.2019.172546.
[23] Zhu D,Hadoke PW,Wu J,et al.Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification[J].Sci Rep,2016,6:24807.DOI:10.1038/srep24807.
[24] Luo J,Tian J,Chou F,et al.Targeting the androgen receptor(AR)with AR degradation enhancer ASC-J9led to increase docetaxel sensitivity via suppressing the p21 expression[J].Cancer Lett,2019,444:35-44.DOI:10.1016/j.canlet.2018.09.025.
[25] Huang M,Zheng L,Xu H,et al.Oxidative stress contributes to vascular calcification in patients with chronic kidney disease[J].J Mol Cell Cardiol,2020,138:256-268.DOI:10.1016/j.yjmcc.2019.12.006.
[26] Xu TH,Sheng Z,Li Y,et al.OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP[J].Life Sci,2020,261:118121.DOI:10.1016/j.lfs.2020.118121.
[27] Feng T,Zhao R,Sun F,et al.TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression[J].Oncogene,2020,39(2):356-367.DOI:10.1038/s41388-019-0991-3.
[28] Ding M,Jiang CY,Zhang Y,et al.SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer[J].J Exp Clin Cancer Res,2020,39(1):28.DOI:10.1186/s13046-019-1516-1.

相似文献/References:

[1]张琳,王晓琳,李小英.雄激素与糖脂代谢的关系[J].国际内分泌代谢杂志,2014,(05):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
 Zhang Lin,Wang Xiaolin,Li Xiaoying..The relationship between testosterone and glycolipid,metabolism[J].International Journal of Endocrinology and Metabolism,2014,(05):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
[2]蔡美丽,张曼娜.雄激素参与男性免疫炎性反应的研究进展[J].国际内分泌代谢杂志,2021,41(06):653.[doi:10.3760/cma.j.cn121383-20200614-06035]
 Cai Meili,Zhang Manna..Research progress of androgens involved in the male immune-inflammatory response[J].International Journal of Endocrinology and Metabolism,2021,41(05):653.[doi:10.3760/cma.j.cn121383-20200614-06035]

备注/Memo

备注/Memo:
通信作者:庞海燕,Email:panghaiyan2014@126.com
基金项目:天津市自然科学基金(19JCYBJC24900)
更新日期/Last Update: 2022-09-10